Page last updated: 2024-08-23
paclitaxel and ys 49
paclitaxel has been researched along with ys 49 in 1 studies
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Chang, KC; Hwa, JS; Jang, HJ; Kim, HJ; Kim, YM; Park, EJ; Park, SW; Tsoyi, K | 1 |
Other Studies
1 other study(ies) available for paclitaxel and ys 49
| Article | Year |
|---|---|
CKD712, a synthetic isoquinoline alkaloid, enhances the anti-cancer effects of paclitaxel in MDA-MB-231 cells through regulation of PTEN.
Topics: Antineoplastic Agents; Apoptosis; bcl-X Protein; Caspase 3; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Drug Synergism; Gene Expression Regulation, Neoplastic; Humans; I-kappa B Kinase; Mammary Glands, Human; NF-kappa B; Paclitaxel; PTEN Phosphohydrolase; RNA, Small Interfering; Signal Transduction; Tetrahydroisoquinolines; Tumor Necrosis Factor-alpha | 2014 |